Journal Watch
-
Home HD: A good start's the key
A look at 95 home HD patients found that those who started treatment in the hospital or with a catheter had far higher rates of hospital stays, changing to another treatment, or death than those who had better starts. For both new patients and those coming to dialysis from a failed transplant, a planned home HD start with a permanent access led to better outcomes.
Read the abstract » | (added 2013-12-10)
Tags:
-
Is there a new way to prevent PD infections? Sorry, honey
Honey has a long history of helping to heal wounds—with no risk of antibiotic resistance. But, a recent trial of the sweet stuff in PD exit site infections did not show a benefit. Researchers asked 186 patients from 26 clinics in Australia and New Zealand to put purified honey on their exit sites, while a control group (185 people) used standard care (or mupirocin if they carried S aureus). The time to first infection was about the same in both groups.
Read the abstract » | (added 2013-11-06)
Tags:
-
Stacking up intensive HD against standard in-center HD
We know that the risk of death is far higher for patients after two days with no HD. Do longer and/or more frequent HD regimens successfully address this problem and save lives? This review compares the impact of different HD regimens on a number of factors, including access problems, burden of therapy, quality of life, residual kidney function, heart disease, bone disease, anemia, hospitalization, and survival.
Read the abstract » | (added 2013-11-06)
Tags:
-
The Brits are doing something right in home HD
Among 166 home HD patients in Manchester, UK (chosen with "liberal selection criteria"), the drop-out rate was far smaller than we tend to see in the US. In 8 years, just 24 patients switched to a different option. Technique survival at home was 98.4% at 1 year, 95.4% at 2 years, and 88.9% at 5 years, excluding death and transplant. Patients older than 60, those with diabetes or heart failure, and those with more comorbidities were more likely to stop doing home HD. The technical error rate was just 0.7% per year.
Read the abstract » | (added 2013-11-06)
Tags:
-
One type of PD catheter offers a significant survival advantage
Coiled? Swan neck? Straight? As it turns out, the catheter shape does matter. A new metaanalysis of 13 randomized controlled trials found that both catheters and people were twice as likely to survive when catheters were straight—not coiled.
Read the abstract » | (added 2013-11-06)
Tags:
-
PD First. It makes sense!
Why is the default US dialysis standard in-center HD, when it doesn't offer the best outcomes, costs more, and offers a poor quality of life? That's the question asked in a new review article that points out the benefits of a PD first strategy. Rather than allowing ease of HD initiation to drive treatment "choice," it makes sense to change the default initiation option to PD.
Read the abstract » | (added 2013-11-06)
Tags:
-
One way to reduce oxidative stress in PD patients
Oxygen is a great thing—in the right amounts. But, too much can wreak cellular havoc and even damage the heart. In people on PD, oxidative stress can hurt the peritoneum, too. Antioxidants to the rescue! A Greek study looked at the impact of vitamins C and E (alone and combined) in 20 people on PD vs. 10 healthy controls. Both of the vitamins reduced oxidative stress markers. (Talk to your doctor before taking any medication, vitamin, or supplement).
Read the abstract » | (added 2013-10-02)
Tags:
-
Risks of biocompatible PD solution
Sugar (dextrose) in PD solution helps remove water from the blood—at a cost. Advanced glycation endpoints (AGEs) formed when the solution is made can harm the peritoneum over time. It would seem to make sense more biocompatible (like the human body) solutions would be better and safer. Some studies have found this, but a new look in the ANZDATA registry of all PD patients from Australia/New Zealand from January 1, 2007 and December 31, 2010 did not. Use of biocompatible PD solution was linked with significantly more (49% more) peritonitis, and far less time to a first bout of the infection.
Read the abstract » | (added 2013-10-02)
Tags:
-
PD may one day help stroke victims
After an ischemic stroke that reduces blood flow, damage to brain cells can occur. High levels of the neurotransmitter glutamate in the blood—but not in brain cells—kills neurons. PD is known to remove glutamate from the blood. A new study in rats has found that using PD helped brain levels of glutamate to bounce back. In the rats, using PD shrunk the stroke damage area—and the rescued brain tissue still worked!
Read the abstract » | (added 2013-10-02)
Tags:
-
What are the challenges for successful home HD?
The UK has actually set a goal in 2002 for home HD of 10-15% of dialysis patients, but has not reached it yet. A new study (BASIC-HHD) is starting to look at the reasons for underuse of a treatment option that offers better results than standard in-center HD. A total of 500 patients will be followed, 200 pre-dialysis, 200 hospital HD, and 100 home HD from across the UK. The predialsyis patients will be followed for a year to better understand their journey to ESRD and renal replacement. They will be interviewed, take psychosocial assessments, and have blood tests. The researchers will also look at the attitudes and practices in dialysis clinics, the economics of home treatment, and care partner concerns.
Read the abstract » | (added 2013-10-02)
Tags: